About Integrated Biosciences
At Integrated, we are focused on advancing small molecule therapeutics for age-related diseases. We have built a first-of-its-kind discovery platform at the intersection of phenotypic models of aging, chemistry, and AI. Backed by top-tier VCs, and with recent publications in Cell (2025), Nature (2024), Nature Aging (2023), and Nature Protocols (2025), we’re rapidly expanding our senior scientific team to accelerate our growing pipeline.